181 related articles for article (PubMed ID: 37624909)
1. PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors.
Gill AL; Wang PH; Lee J; Hudson WH; Ando S; Araki K; Hu Y; Wieland A; Im S; Gavora A; Medina CB; Freeman GJ; Hashimoto M; Reiner SL; Ahmed R
Sci Immunol; 2023 Aug; 8(86):eadg0539. PubMed ID: 37624909
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
Jadhav RR; Im SJ; Hu B; Hashimoto M; Li P; Lin JX; Leonard WJ; Greenleaf WJ; Ahmed R; Goronzy JJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14113-14118. PubMed ID: 31227606
[TBL] [Abstract][Full Text] [Related]
3. Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
Mariniello A; Nasti TH; Chang DY; Hashimoto M; Malik S; McManus DT; Lee J; McGuire DJ; Cardenas MA; Umana P; Nicolini V; Antia R; Saha A; Buchwald Z; Kissick H; Ghorani E; Novello S; Sangiolo D; Scagliotti GV; Ramalingam SS; Ahmed R
Clin Cancer Res; 2024 May; 30(9):1833-1845. PubMed ID: 37992307
[TBL] [Abstract][Full Text] [Related]
4. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
[TBL] [Abstract][Full Text] [Related]
5. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1
Hudson WH; Gensheimer J; Hashimoto M; Wieland A; Valanparambil RM; Li P; Lin JX; Konieczny BT; Im SJ; Freeman GJ; Leonard WJ; Kissick HT; Ahmed R
Immunity; 2019 Dec; 51(6):1043-1058.e4. PubMed ID: 31810882
[TBL] [Abstract][Full Text] [Related]
6. TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection.
Hu Y; Hudson WH; Kissick HT; Medina CB; Baptista AP; Ma C; Liao W; Germain RN; Turley SJ; Zhang N; Ahmed R
J Exp Med; 2022 Oct; 219(10):. PubMed ID: 35980386
[TBL] [Abstract][Full Text] [Related]
7. Role of PD-1 during effector CD8 T cell differentiation.
Ahn E; Araki K; Hashimoto M; Li W; Riley JL; Cheung J; Sharpe AH; Freeman GJ; Irving BA; Ahmed R
Proc Natl Acad Sci U S A; 2018 May; 115(18):4749-4754. PubMed ID: 29654146
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and anatomic location of PD-1
Im SJ; Obeng RC; Nasti TH; McManus D; Kamphorst AO; Gunisetty S; Prokhnevska N; Carlisle JW; Yu K; Sica GL; Cardozo LE; Gonçalves ANA; Kissick HT; Nakaya HI; Ramalingam SS; Ahmed R
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221985120. PubMed ID: 37782797
[TBL] [Abstract][Full Text] [Related]
9. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
11. IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation.
Lee J; Lee K; Bae H; Lee K; Lee S; Ma J; Jo K; Kim I; Jee B; Kang M; Im SJ
Front Immunol; 2023; 14():1117092. PubMed ID: 37409128
[TBL] [Abstract][Full Text] [Related]
12. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
Front Immunol; 2022; 13():869768. PubMed ID: 35774790
[TBL] [Abstract][Full Text] [Related]
13. Functional HPV-specific PD-1
Eberhardt CS; Kissick HT; Patel MR; Cardenas MA; Prokhnevska N; Obeng RC; Nasti TH; Griffith CC; Im SJ; Wang X; Shin DM; Carrington M; Chen ZG; Sidney J; Sette A; Saba NF; Wieland A; Ahmed R
Nature; 2021 Sep; 597(7875):279-284. PubMed ID: 34471285
[TBL] [Abstract][Full Text] [Related]
14. Novel Lymphocytic Choriomeningitis Virus Strain Sustains Abundant Exhausted Progenitor CD8 T Cells without Systemic Viremia.
Beura LK; Scott MC; Pierson MJ; Joag V; Wijeyesinghe S; Semler MR; Quarnstrom CF; Busman-Sahay K; Estes JD; Hamilton SE; Vezys V; O'Connor DH; Masopust D
J Immunol; 2022 Nov; 209(9):1691-1702. PubMed ID: 36122933
[TBL] [Abstract][Full Text] [Related]
15. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
[TBL] [Abstract][Full Text] [Related]
16. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.
Vezys V; Penaloza-MacMaster P; Barber DL; Ha SJ; Konieczny B; Freeman GJ; Mittler RS; Ahmed R
J Immunol; 2011 Aug; 187(4):1634-42. PubMed ID: 21742975
[TBL] [Abstract][Full Text] [Related]
17. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.
Penaloza-MacMaster P; Kamphorst AO; Wieland A; Araki K; Iyer SS; West EE; O'Mara L; Yang S; Konieczny BT; Sharpe AH; Freeman GJ; Rudensky AY; Ahmed R
J Exp Med; 2014 Aug; 211(9):1905-18. PubMed ID: 25113973
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
19. Early generation of a precursor CD8 T cell that can adapt to acute or chronic viral infection.
McManus DT; Valanparambil RM; Medina CB; Hu Y; Scharer CD; Sobierajska E; Chang DY; Wieland A; Lee J; Nasti TH; Hashimoto M; Ross JL; Prokhnevska N; Cardenas MA; Gill AL; Clark EC; Abadie K; Kueh HY; Kaye J; Au-Yeung BB; Kissick HT; Ahmed R
Res Sq; 2024 Feb; ():. PubMed ID: 38410458
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.
West EE; Jin HT; Rasheed AU; Penaloza-Macmaster P; Ha SJ; Tan WG; Youngblood B; Freeman GJ; Smith KA; Ahmed R
J Clin Invest; 2013 Jun; 123(6):2604-15. PubMed ID: 23676462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
